PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung Cancer

Condition:   Carcinoma, Non-Small-Cell Lung Intervention:   Drug: PF-06463922 (Lorlatinb) Sponsors:   Fondazione Ricerca Traslazionale;   Clinical Research Technology S.r.l. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials